Featured Products
Current Products
Pipeline
Research and Development
Pipeline

Through our in-house expertise and joint research and development efforts with universities and research institutions in China, Simcere has a robust pipeline of new pharmaceuticals under development.

As of Oct 31, 2008, we had 12 product candidates at various stages of development. Details of the product candidates that we believe have the highest potential for commercialization over the coming years are summarized below:
 
Product Candidate Therapeutic Effects and Scope of Applications Status
Iguratimod Tablets Treatment of Osteoarthritis and Rheumatoid Arthritis New Drug Application
Palonosetron Injection Nausea and Vomiting Associated with Chemotherapy New Drug Application
Endu Combined with TC Chemotherapy Oncology Phase Ⅲ of clinical trials
Endu Combined with NP Chemotherapy for Post-surgery Patients Oncology Phase Ⅲ of clinical trials
Dual Functions Rh-RGD-Hirudin for Injection Anti-thrombus Phase Ⅱ
Bendamustine for Injection Oncology Phase Ⅰ
Triflusal Cardiocerebral Vascular Disease Phase Ⅰ

SIM6802 Protein Tyrosine Kinase Inhibitor

 Oncology Pre-clinical

SIM010603 Protein Tyrosine Kinase Inhibitor

 Oncology Pre-clinical

SIM0710 Endu-PEG Injection

 Oncology Drug Optimization

SIM0702 Endu-Microsphere Injection

 Oncology Drug Optimization
SIM071201 Cerebrovascular Diseases Drug Optimization
 
 
 
 
Copyright 2000-2007 www.simcere.com/english All rights reserved.
tel 86-25-85566666 fax 86-25-85471729
Design by 71nc.com